Outcomes for patients undergoing endoscopic therapy for Barrett’s related neoplasia: over 10-year experience from the Dutch Barrett Expert Centers

Recruiting

• Conditions: Barrett's esophagus; Barrett's related neoplasia

• Registration Number: NL-OMON29089
• Lead Sponsor: ead site:Academic Medical Center Amsterdam (AMC)Collaborating centers:•Sint Antonius Hospital Nieuwegein•Catharina Hospital, Eindhoven•University Medical Center, Utrecht•Isala Clinics, Zwolle•Erasmus Medical Center, Rotterdam•Haga Hospital, Den Haag•University Medical Center, Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 2000

Inclusion Criteria

1)Males or females, all ages

2)Presence of Barrett’s esophagus, with presence of intestinal metaplasia in histologic assessment.

Exclusion Criteria

1)Objection against participation in this study, through an opt-out card or e-mail

2)Referral for surgery after the work-up endoscopy for advanced EAC

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary objective is to determine the proportion of patients with successful eradication of BE after endoscopic therapy. The primary endpoint will be the proportion of patients with a successful complete eradication of Barrett’s neoplasia (CE-Neo) after the treatment phase.